Fidelity International
TSBX

Fidelity International’s Turnstone Biologics TSBX Stock Holding History

Fidelity International’s Portfolio TSBX Stock Details TSBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-192,657
Closed -$95.4K – 966
2024
Q4 		$95.4K Hold
192,657
– – ﹤0.01% 846
2024
Q3 		$107K Hold
192,657
– – ﹤0.01% 838
2024
Q2 		$505K Hold
192,657
– – ﹤0.01% 754
2024
Q1 		$505K Hold
192,657
– – ﹤0.01% 760
2023
Q4 		$490K Hold
192,657
– – ﹤0.01% 731
2023
Q3 		$759K Buy
+192,657
New +$1.72M ﹤0.01% 700

Other funds holding TSBX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity International's TSBX Position: Q1 2025 in Review

Fidelity International sold out of Turnstone Biologics (TSBX) in Q1 2025, closing a stake of 192,657 shares — an estimated $95.4K sold.

Fidelity International first reported a position in TSBX in Q3 2023 and held it in 6 quarters. The position peaked at $759K in Q3 2023. 23 funds tracked by Wall St. Rank hold TSBX as of Q1 2025.

  • Fidelity International reported no remaining Turnstone Biologics position as of Q1 2025 after selling out during the quarter.
  • Fidelity International sold 192,657 Turnstone Biologics shares in Q1 2025, an estimated $95.4K.
  • Fidelity International first reported a position in Turnstone Biologics in Q3 2023 and held it in 6 quarters.
  • Fidelity International's Turnstone Biologics position peaked at $759K in Q3 2023.
  • 23 funds tracked by Wall St. Rank held Turnstone Biologics as of Q1 2025.

Based on Fidelity International's 13F filing for Q1 2025, filed 12 May 2025.